Canadian Biomaterials Society
La Société Canadienne des Biomatériaux

Dear CBS members, Thank you for participating in the voting process for the different positions at the Board of Directors...

Hi We re organizing a zoom-inar featuring four Canadian professors working at the frontline of battling COVID-19 Please find the details below The event will take place on May 22nd from 2 30-4 30 pm EDT via Zoom https bit...

Hi everyone, Here is our Zoom link for our upcoming virtual CBS Annaual General Meeting which will be held on Friday, May 22nd, 2020 from 12 - 2 pm EST...

Dear CBS Members, The Annual General Meeting AGM of the Canadian Biomaterials Society CBS will take place on Friday, May 22nd, 2020, 12 2 pm EDT through Zoom video-conference...

Vascular tissue engineering usually relies on the cellularization of scaffold materials with vascular cells with the ultimate aim to produce artificial living artery equivalents overcoming the drawbacks of current vascular grafts, especially for small diameter vessels...

Tumors behavior involves complicated molecular biology and correspondingly complicated dynamics. Primary malignant tumors originate from small numbers of cells that go through an avascular devoid of blood vessels mode at their early stage of growth 1 ...

Poly amino acid ester phosphazenes derived from -amino acids P APz are one of the most widely studied polyphosphazene derivatives in tissue engineering due to their biodegradation and biological properties...

Tracheal injury, stenosis, and malignancy demand surgical management and repair. While end-to-end anastomosis can treat smaller lesions, it is limited for larger lesions as those greater than half the length of an adult trachea and a third of the length of a pediatric trachea cannot be safely resected1...

There is a significant need to evaluate the efficacy and safety of the potential drug candidates in early-stage of the development pipeline to prevent skyrocketing costs of failure in the late-stages of clinical trials or drugs attrition from the market 1...